Literature DB >> 34818667

The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.

Yang Liu1,2, Jianying Liu2,3,4, Kenneth S Plante2,3,4, Jessica A Plante2,3,4, Xuping Xie1, Xianwen Zhang1, Zhiqiang Ku5, Zhiqiang An5, Dionna Scharton2,3,4, Craig Schindewolf2,4, Steven G Widen1, Vineet D Menachery2,4, Pei-Yong Shi6,7, Scott C Weaver8,9,10.   

Abstract

The B.1.1.7 variant (also known as Alpha) of SARS-CoV-2, the cause of the COVID-19 pandemic, emerged in the UK in the summer of 2020. The prevalence of this variant increased rapidly owing to an increase in infection and/or transmission efficiency1. The Alpha variant contains 19 nonsynonymous mutations across its viral genome, including 8 substitutions or deletions in the spike protein that interacts with cellular receptors to mediate infection and tropism. Here, using a reverse genetics approach, we show that of the 8 individual spike protein substitutions, only N501Y resulted in consistent fitness gains for replication in the upper airway in a hamster model as well as in primary human airway epithelial cells. The N501Y substitution recapitulated the enhanced viral transmission phenotype of the eight mutations in the Alpha spike protein, suggesting that it is a major determinant of the increased transmission of the Alpha variant. Mechanistically, the N501Y substitution increased the affinity of the viral spike protein for cellular receptors. As suggested by its convergent evolution in Brazil, South Africa and elsewhere2,3, our results indicate that N501Y substitution is an adaptive spike mutation of major concern.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34818667      PMCID: PMC8900207          DOI: 10.1038/s41586-021-04245-0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  3 in total

1.  Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.

Authors:  Jasper Fuk-Woo Chan; Anna Jinxia Zhang; Shuofeng Yuan; Vincent Kwok-Man Poon; Chris Chung-Sing Chan; Andrew Chak-Yiu Lee; Wan-Mui Chan; Zhimeng Fan; Hoi-Wah Tsoi; Lei Wen; Ronghui Liang; Jianli Cao; Yanxia Chen; Kaiming Tang; Cuiting Luo; Jian-Piao Cai; Kin-Hang Kok; Hin Chu; Kwok-Hung Chan; Siddharth Sridhar; Zhiwei Chen; Honglin Chen; Kelvin Kai-Wang To; Kwok-Yung Yuen
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

2.  Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.

Authors:  Yushun Wan; Jian Shang; Rachel Graham; Ralph S Baric; Fang Li
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

  3 in total
  106 in total

1.  Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity.

Authors:  Mohamed Haddad; Roger Gaudreault; Gabriel Sasseville; Phuong Trang Nguyen; Hannah Wiebe; Theo Van De Ven; Steve Bourgault; Normand Mousseau; Charles Ramassamy
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

2.  SARS-CoV-2 variants and vaccination.

Authors:  Yang Liu; Jianying Liu; Pei-Yong Shi
Journal:  Zoonoses (Burlingt)       Date:  2022-02-08

3.  Animal models in SARS-CoV-2 research.

Authors:  Hin Chu; Jasper Fuk-Woo Chan; Kwok-Yung Yuen
Journal:  Nat Methods       Date:  2022-04       Impact factor: 28.547

Review 4.  SARS-CoV-2 pathogenesis.

Authors:  Mart M Lamers; Bart L Haagmans
Journal:  Nat Rev Microbiol       Date:  2022-03-30       Impact factor: 60.633

5.  Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles.

Authors:  Abdullah M Syed; Taha Y Taha; Takako Tabata; Irene P Chen; Alison Ciling; Mir M Khalid; Bharath Sreekumar; Pei-Yi Chen; Jennifer M Hayashi; Katarzyna M Soczek; Melanie Ott; Jennifer A Doudna
Journal:  Science       Date:  2021-11-04       Impact factor: 47.728

6.  Whole genome sequencing analysis of SARS-CoV-2 from Malaysia: From alpha to Omicron.

Authors:  Choo Yee Yu; Sie Yeng Wong; Nancy Woan Charn Liew; Narcisse Joseph; Zunita Zakaria; Isa Nurulfiza; Hui Jen Soe; Rachna Kairon; Syafinaz Amin-Nordin; Hui Yee Chee
Journal:  Front Med (Lausanne)       Date:  2022-09-23

Review 7.  A comparative overview of SARS-CoV-2 and its variants of concern.

Authors:  Aqeel Ahmad; Mohammed Ali Mullah Fawaz; Arafeen Aisha
Journal:  Infez Med       Date:  2022-09-01

Review 8.  Evolutionary Traits and Genomic Surveillance of SARS-CoV-2 in South America.

Authors:  Pablo A Ortiz-Pineda; Carlos H Sierra-Torres
Journal:  Glob Health Epidemiol Genom       Date:  2022-05-18

9.  An early warning system for emerging SARS-CoV-2 variants.

Authors:  Lorenzo Subissi; Anne von Gottberg; Lipi Thukral; Nathalie Worp; Bas B Oude Munnink; Surabhi Rathore; Laith J Abu-Raddad; Ximena Aguilera; Erik Alm; Brett N Archer; Homa Attar Cohen; Amal Barakat; Wendy S Barclay; Jinal N Bhiman; Leon Caly; Meera Chand; Mark Chen; Ann Cullinane; Tulio de Oliveira; Christian Drosten; Julian Druce; Paul Effler; Ihab El Masry; Adama Faye; Simani Gaseitsiwe; Elodie Ghedin; Rebecca Grant; Bart L Haagmans; Belinda L Herring; Shilpa S Iyer; Zyleen Kassamali; Manish Kakkar; Rebecca J Kondor; Juliana A Leite; Yee-Sin Leo; Gabriel M Leung; Marco Marklewitz; Sikhulile Moyo; Jairo Mendez-Rico; Nada M Melhem; Vincent Munster; Karen Nahapetyan; Djin-Ye Oh; Boris I Pavlin; Thomas P Peacock; Malik Peiris; Zhibin Peng; Leo L M Poon; Andrew Rambaut; Jilian Sacks; Yinzhong Shen; Marilda M Siqueira; Sofonias K Tessema; Erik M Volz; Volker Thiel; Sylvie van der Werf; Sylvie Briand; Mark D Perkins; Maria D Van Kerkhove; Marion P G Koopmans; Anurag Agrawal
Journal:  Nat Med       Date:  2022-06       Impact factor: 87.241

10.  Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2.

Authors:  Ryuta Uraki; Maki Kiso; Shun Iida; Masaki Imai; Emi Takashita; Makoto Kuroda; Peter J Halfmann; Samantha Loeber; Tadashi Maemura; Seiya Yamayoshi; Seiichiro Fujisaki; Zhongde Wang; Mutsumi Ito; Michiko Ujie; Kiyoko Iwatsuki-Horimoto; Yuri Furusawa; Ryan Wright; Zhenlu Chong; Seiya Ozono; Atsuhiro Yasuhara; Hiroshi Ueki; Yuko Sakai-Tagawa; Rong Li; Yanan Liu; Deanna Larson; Michiko Koga; Takeya Tsutsumi; Eisuke Adachi; Makoto Saito; Shinya Yamamoto; Masao Hagihara; Keiko Mitamura; Tetsuro Sato; Masayuki Hojo; Shin-Ichiro Hattori; Kenji Maeda; Riccardo Valdez; Moe Okuda; Jurika Murakami; Calvin Duong; Sucheta Godbole; Daniel C Douek; Ken Maeda; Shinji Watanabe; Aubree Gordon; Norio Ohmagari; Hiroshi Yotsuyanagi; Michael S Diamond; Hideki Hasegawa; Hiroaki Mitsuya; Tadaki Suzuki; Yoshihiro Kawaoka
Journal:  Nature       Date:  2022-05-16       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.